Sofosbuvir Tablets (Dongyangguang) – 400mg × 28 Tablets

Sofosbuvir Tablets (Dongyangguang) – 400mg × 28 Tablets

$2.00

Dongyangguang Sofosbuvir Tablets deliver 400?mg per tablet, with 28 tablets per box (4 blisters of 7). Manufactured by Yichang Dongyangguang Changjiang Pharmaceuticals under Chinese approval H20233865 . Ideal for preclinical hepatitis C virus (HCV) research focusing on viral replication, resistance, and antiviral screening. ?? For laboratory and research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

描述

Sofosbuvir is a nucleotide analog prodrug that targets the HCV NS5B RNA-dependent RNA polymerase, critical to viral replication . As the active ingredient in the brand Sovaldi, it is a key compound in antiviral research. Dongyangguang’s formulation offers the same active molecule with local approval for research purposes. Use cases include in vitro replication assays, resistance models, combination therapy studies, and hepatocyte metabolism research.


Sofosbuvir Tablets Product Specifications

Parameter Details
Product Name Sofosbuvir Tablets (Dongyangguang)
Generic Name Sofosbuvir
CAS Number 1190307?88?0
Molecular Formula C??H??FN?O?P
Molecular Weight ~529.45?g/mol
Strength 400?mg per tablet
Pack Size 0.4?g × 28 tablets
Dosage Form Film-coated oral tablet
Approval Number H20233865 (NMPA China)
Manufacturer Yichang Dongyangguang Changjiang Pharma Co., Ltd.
Barcode 6933346881016
Storage Conditions Store ??30?°C in a cool, dry place
Intended Use Laboratory research—HCV virology, NS5B inhibitor studies, antiviral screening

Sofosbuvir Tablets Mechanism of Action

Sofosbuvir is metabolized into a triphosphate form in hepatocytes, which then competitively inhibits the HCV NS5B polymerase, terminating viral RNA synthesis, and offering a high barrier to resistance


Sofosbuvir Tablets Research Applications

  • HCV replication assays targeting NS5B

  • Antiviral resistance modeling against direct-acting antivirals

  • Combination treatment studies (e.g., with NS5A or protease inhibitors)

  • Pharmacokinetic and metabolic activation studies in hepatic cells

  • Structure–activity relationship research in viral polymerase inhibition


Safety & Handling

  • Use under research-grade lab conditions only

  • Standard PPE required: gloves, lab coat, eye protection

  • Synthesized to pharmaceutical standards but not for clinical administration

  • Store in original packaging, protected from heat and moisture


Core Keywords

sofosbuvir tablets, Dongyangguang Sofosbuvir, CAS 1190307-88-0, HCV NS5B inhibitor, hepatitis C antiviral compound, preclinical HCV drug, antiviral research sofosbuvir, NMPA H20233865, Yichang Dongyangguang


Research Use Disclaimer

This product is exclusively for laboratory and research use. It is not approved for clinical, veterinary, diagnostic, or therapeutic use. Misuse may result in legal or health implications. Use only under institutional protocol.

其他信息

重量 1 公斤
尺寸 34 × 32 × 34 厘米

评价

目前还没有评价

成为第一个“Sofosbuvir Tablets (Dongyangguang) – 400mg × 28 Tablets” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare